Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma (scientific article published in June 2004)

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

Q28306437

Cell proliferation, apoptosis, and expression of cyclin D1 and cyclin E as potential biomarkers in tamoxifen-treated mammary tumors

Q28570272

Cancer cell cycles

Q29547756

G1 phase progression: cycling on cue

Q29615162

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

Q29618409

Cyclins and breast cancer

Q33538420

Immunohistological demonstration of progesterone receptor in breast carcinomas: correlation with radioligand binding assays and oestrogen receptor immunohistology

Q33839063

Breast carcinoma etiology: current knowledge and new insights into the effects of reproductive and hormonal risk factors in black and white populations

Q33855660

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

Q34415244

Multiparameter analyses of cell cycle regulatory proteins in human breast cancer: a key to definition of separate pathways in tumorigenesis

Q34554750

Ethnicity-related variation in breast cancer risk factors

Q35030234

Histopathology of breast cancer among African-American women

Q35030252

p21WAF1 immunohistochemical expression in breast carcinoma: correlations with clinicopathological data, oestrogen receptor status, MIB1 expression, p53 gene and protein alterations and relapse-free survival

Q36135459

Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status

Q36136157

Immunohistological study of oestrogen receptors in breast carcinomas that are biochemically receptor negative

Q37256166

Monoclonal antibodies against recombinant parts of the Ki-67 antigen (MIB 1 and MIB 3) detect proliferating cells in microwave-processed formalin-fixed paraffin sections

Q38486858

Breast cancer stage at diagnosis: Caucasians versus Afro-Americans

Q40424981

Racial/ethnic variation in clinical presentation, treatment, and survival among breast cancer patients under age 35.

Q40614629

Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study

Q40701807

The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node

Q40720961

Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group

Q40820515

Breast cancer in black women

Q40976296

Breast cancer in African American women: epidemiology and tumor biology

Q41185267

Association of p27Kip1 levels with recurrence and survival in patients with stage C prostate carcinoma

Q42457106

Overexpression of the p16 cell cycle inhibitor in breast cancer is associated with a more malignant phenotype

Q43716774

Ethnicity related differences in the survival of young breast carcinoma patients

Q43725090

P16INK4a protein expression is associated with poor survival of the breast cancer patients after CMF chemotherapy.

Q43862141

Race, socioeconomic status, and breast cancer treatment and survival

Q44271644

Differences in breast cancer stage, treatment, and survival by race and ethnicity

Q45287347

Breast carcinoma tumor characteristics in black and white women

Q46230797

Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-

Q46325752

African-American ethnicity, socioeconomic status, and breast cancer survival: a meta-analysis of 14 studies involving over 10,000 African-American and 40,000 White American patients with carcinoma of the breast

Q46371503

Dual effect of parity on breast cancer risk in African-American women.

Q46720906

Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States

Q46865190

Cyclin D1 and prognosis in human breast cancer

Q47335186

Color modification of diaminobenzidine (DAB) precipitation by metallic ions and its application for double immunohistochemistry

Q50932720

Treatment plans for black and white women with stage II node-positive breast cancer. The National Cancer Institute Black/White Cancer Survival Study experience

Q67573460

Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues

Q67594938

Discrepancies of the biochemical and immunohistochemical estrogen receptor assays in breast cancer

Q68467345

Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro

Q68584387

Immunohistochemical estrogen receptor determination in paraffin-embedded tissue. Prediction of response to hormonal treatment in advanced breast cancer

Q69746563

Inversely correlated expression of p16 and Rb protein in non-small cell lung cancers: an immunohistochemical study

Q71058135

Ethnic differences in risk and prognostic factors for breast cancer

Q71067158

Oral contraceptives and breast cancer risk among younger women

Q72335615

The use of antiavidin antibody and avidin-biotin-peroxidase complex in immunoperoxidase technics

Q72640463

Deregulation of cyclin E and D1 in breast cancer is associated with inactivation of the retinoblastoma protein

Q73034011

Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients

Q73034313

G1-S transition defects occur in most breast cancers and predict outcome

Q73207809

Retinoblastoma and p16 proteins in mammary carcinoma: their relationship to cyclin D1 and histopathological parameters

Q74292669

Disaggregating the effects of race and poverty on breast cancer outcomes

Q77870600

Prevalence of aberrant methylation of p14ARF over p16INK4a in some human primary tumors

Q79175646

P433

issue

P407

language of work or name

English

Q1860

P304

page(s)

2533-2542

P577

publication date

2004-06-01

P1433

published in

Cancer

Q326041

P1476

title

Racial differences in the expression of cell cycle-regulatory proteins in breast carcinoma

P478

volume

100

Reverse relations

cites work (P2860)

Q34128523	A cluster randomized controlled trial to increase breast cancer screening among African American women: the black cosmetologists promoting health program.
Q33280428	A mammography database and view system for African-American patients.
Q34213855	A phase 2 study of 16α-[18F]-fluoro-17β-estradiol positron emission tomography (FES-PET) as a marker of hormone sensitivity in metastatic breast cancer (MBC).
Q34315367	A population-based study of Kurdish breast cancer in northern Iraq: hormone receptor and HER2 status. A comparison with Arabic women and United States SEER data
Q36596729	A review of the ethnic differences in breast cancer
Q34756445	A study to investigate the role of p27 and cyclin E immunoexpression as a prognostic factor in early breast carcinoma
Q43667672	Age at breast cancer diagnosis in populations of african and European ancestry
Q43119160	Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report
Q35151440	Ancestry dependent DNA methylation and influence of maternal nutrition
Q33748595	Assessing the Racial and Ethnic Disparities in Breast Cancer Mortality in the United States
Q34619821	Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women
Q44446068	Breast Cancer Disparities at Home and Abroad: A Review of the Challenges and Opportunities for System-Level Change
Q36700955	Breast cancer epidemiology in blacks and whites: disparities in incidence, mortality, survival rates and histology
Q39011572	Breast cancer in sub-Saharan Africa: how does it relate to breast cancer in African-American women?
Q37107535	Breast cancer survival disparity between African American and Caucasian women in Arkansas: A race-by-grade analysis
Q37456793	Breast cancers from black women exhibit higher numbers of immunosuppressive macrophages with proliferative activity and of crown-like structures associated with lower survival compared to non-black Latinas and Caucasians.
Q36830014	Cell Proliferation (KI-67) Expression Is Associated with Poorer Prognosis in Nigerian Compared to British Breast Cancer Women
Q38780267	Centrosome amplification: a suspect in breast cancer and racial disparities
Q37494588	Characteristics and treatment modalities for African American women diagnosed with stage III breast cancer
Q34412356	Cyclin E in normal and neoplastic cell cycles
Q42515557	Differences in breast carcinoma characteristics in newly diagnosed African-American and Caucasian patients: a single-institution compilation compared with the National Cancer Institute's Surveillance, Epidemiology, and End Results database
Q37624199	Differences in gene and protein expression and the effects of race/ethnicity on breast cancer subtypes
Q33410258	Differences in the tumor microenvironment between African-American and European-American breast cancer patients
Q34278253	Differential expression of breast cancer-associated genes between stage- and age-matched tumor specimens from African- and Caucasian-American Women diagnosed with breast cancer
Q36998212	Disparities in breast cancer outcomes between Caucasian and African American women: a model for describing the relationship of biological and nonbiological factors
Q37191364	Disparities in breast cancer treatment and outcomes: biological, social, and health system determinants and opportunities for research
Q39852682	Effects of an outreach and internal navigation program on breast cancer diagnosis in an urban cancer center with a large African-American population
Q64917329	Endocrine Therapy Nonadherence and Discontinuation in Black and White Women.
Q47915287	Ethnicity and breast cancer characteristics in Kenya
Q33630849	Expression of aldehyde dehydrogenase 1 (ALDH1) is associated with basal-like markers and features of aggressive tumours in African breast cancer
Q37065947	Factors associated with receipt of breast cancer adjuvant chemotherapy in a diverse population-based sample
Q35573190	Genome-wide copy number alterations in subtypes of invasive breast cancers in young white and African American women
Q92916937	Health and Racial Disparity in Breast Cancer
Q39846699	High prevalence of triple-negative tumors in an urban cancer center
Q37205299	Higher incidence of aggressive breast cancers in African-American women: a review.
Q37389790	Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancer
Q37577918	Influence of obesity on breast cancer receptor status and prognosis
Q35144499	Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale
Q44466899	Long-term outcomes and clinicopathologic differences of African-American versus white patients treated with breast conservation therapy for early-stage breast cancer
Q42510389	Molecular characteristics and prognostic features of breast cancer in Nigerian compared with UK women
Q92524865	Race and delays in breast cancer treatment across the care continuum in the Carolina Breast Cancer Study
Q34796332	Race and the prognostic influence of p53 in women with breast cancer.
Q81318609	Race modifies the association between breast carcinoma pathologic prognostic indicators and the positive status for HER-2/neu
Q31171709	Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data, and modeling assumptions
Q39441334	Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?
Q36794927	Racial differences in clinical outcomes from metastatic breast cancer: a pooled analysis of CALGB 9342 and 9840--Cancer and Leukemia Group B.
Q47692378	Racial disparity in breast cancer: can it be mattered for prognosis and therapy
Q41356781	Racial disparity in survival from early breast cancer in the department of defense healthcare system
Q46152783	Sleep in older African Americans and Caucasians at risk for sleep-disordered breathing
Q55287276	TP53 protein levels, RNA-based pathway assessment, and race among invasive breast cancer cases.
Q91686056	The Black identity, hair product use, and breast cancer scale
Q24289471	The epidemiology of triple-negative breast cancer, including race
Q36333924	Triple-negative breast cancer and obesity in a rural Appalachian population
Q51050853	Triple-negative breast cancer in Hispanic patients: high prevalence, poor prognosis, and association with menopausal status, body mass index, and parity.
Q98467125	Understanding breast cancer disparities-a multi-scale challenge
Q47274272	Within-stage racial differences in tumor size and number of positive lymph nodes in women with breast cancer